Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications
- PMID: 27469369
- DOI: 10.1152/ajpgi.00442.2015
Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications
Abstract
Opioids are one of the most prescribed drug classes for treating acute pain. However, chronic use is often associated with tolerance as well as debilitating side effects, including nausea and dependence, which are mediated by the central nervous system, as well as constipation emerging from effects on the enteric nervous system. These gastrointestinal (GI) side effects limit the usefulness of opioids in treating pain in many patients. Understanding the mechanism(s) of action of opioids on the nervous system that shows clinical benefit as well as those that have unwanted effects is critical for the improvement of opioid drugs. The opioidergic system comprises three classical receptors (μ, δ, κ) and a nonclassical receptor (nociceptin), and each of these receptors is expressed to varying extents by the enteric and intestinal extrinsic sensory afferent nerves. The purpose of this review is to discuss the role that the opioidergic system has on enteric and extrinsic afferent nerves in the lower GI tract in health and diseases of the lower GI tract, particularly inflammatory bowel disease and irritable bowel syndrome, and the implications of opioid treatment on clinical outcomes. Consideration is also given to emerging developments in our understanding of the immune system as a novel source of endogenous opioids and the mechanisms underlying opioid tolerance, including the potential influence of opioid receptor splice variants and heteromeric complexes.
Keywords: immune; inflammatory bowel diseases; irritable bowel syndrome; nervous system; opioid.
Copyright © 2016 the American Physiological Society.
Similar articles
-
Expression and physiology of opioid receptors in the gastrointestinal tract.Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):3-10. doi: 10.1097/MED.0000000000000219. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26702845 Review.
-
Insights into the Role of Opioid Receptors in the GI Tract: Experimental Evidence and Therapeutic Relevance.Handb Exp Pharmacol. 2017;239:363-378. doi: 10.1007/164_2016_116. Handb Exp Pharmacol. 2017. PMID: 28204957 Free PMC article. Review.
-
Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.Neurosci Lett. 2004 May 6;361(1-3):192-5. doi: 10.1016/j.neulet.2003.12.004. Neurosci Lett. 2004. PMID: 15135926 Review.
-
Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression.Neuropharmacology. 2018 Mar 15;131:238-255. doi: 10.1016/j.neuropharm.2017.12.032. Epub 2017 Dec 20. Neuropharmacology. 2018. PMID: 29273520 Review.
-
Preclinical studies of opioids and opioid antagonists on gastrointestinal function.Neurogastroenterol Motil. 2004 Oct;16 Suppl 2:46-53. doi: 10.1111/j.1743-3150.2004.00555.x. Neurogastroenterol Motil. 2004. PMID: 15357851 Review.
Cited by
-
Protagonist Role of Opioidergic System on Post-Traumatic Stress Disorder and Associated Pain.Psychiatry Investig. 2020 Jun;17(6):506-516. doi: 10.30773/pi.2020.0002. Epub 2020 Jun 3. Psychiatry Investig. 2020. PMID: 32492768 Free PMC article.
-
The effects of fentanyl, oxycodone, and butorphanol on gastrointestinal function in patients undergoing laparoscopic hysterectomy: a prospective, double-blind, randomized controlled trial.BMC Anesthesiol. 2022 Feb 24;22(1):53. doi: 10.1186/s12871-022-01594-9. BMC Anesthesiol. 2022. PMID: 35209847 Free PMC article. Clinical Trial.
-
The efficacy and safety of difelikefalin for pruritus in hemodialysis patients: a systematic review and meta-analysis of randomized controlled trials.Ren Fail. 2024 Dec;46(2):2384590. doi: 10.1080/0886022X.2024.2384590. Epub 2024 Aug 1. Ren Fail. 2024. PMID: 39091079 Free PMC article.
-
Naldemedine: A New Option for OIBD.J Pain Res. 2020 May 26;13:1209-1222. doi: 10.2147/JPR.S243435. eCollection 2020. J Pain Res. 2020. PMID: 32547183 Free PMC article. Review.
-
µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients.Neurogastroenterol Motil. 2019 Nov;31(11):e13688. doi: 10.1111/nmo.13688. Epub 2019 Jul 23. Neurogastroenterol Motil. 2019. PMID: 31336406 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials